IVA
Inventiva
Stock NASDAQ – Stock Market Prices, News & Analysis
Société biopharmaceutique française spécialisée dans le développement de traitements innovants pour les maladies métaboliques et les pathologies rares.
Inventiva
IVA
Société biopharmaceutique française spécialisée dans le développement de traitements innovants pour les maladies métaboliques et les pathologies rares.
Price history of Inventiva
Price history of Inventiva
Performance & Momentum
Inventiva Resumes Trading After $150M US Fundraising
Inventiva, a biopharmaceutical company specializing in oral therapies for metabolic steatohepatitis (NASH), has resumed trading of its ordinary shares on Euronext Paris following a temporary suspension. The company completed a capital increase via American Depositary Shares (ADS) of approximately $150 million, exceeding the initially planned amount. This fundraising aims to strengthen financial resources to support clinical development. Analysts remain confident with stable valuation despite a slight risk adjustment, which may support Inventiva's stock momentum in the medium term.
Similar stocks to Inventiva
Take control
of your investments
Track your portfolios, analyze your performance and receive personalized insights to invest with strategy.
- Real-time multi-portfolio tracking
- AI analysis of your positions
- Counter your cognitive biases
